ArticleJCO precision oncology2022

Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study.

Olivia Ruhen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.